JP2005506369A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005506369A5 JP2005506369A5 JP2003537629A JP2003537629A JP2005506369A5 JP 2005506369 A5 JP2005506369 A5 JP 2005506369A5 JP 2003537629 A JP2003537629 A JP 2003537629A JP 2003537629 A JP2003537629 A JP 2003537629A JP 2005506369 A5 JP2005506369 A5 JP 2005506369A5
- Authority
- JP
- Japan
- Prior art keywords
- irbesartan
- pharmaceutical composition
- hydrochlorothiazide
- composition according
- diuretics
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002947 C09CA04 - Irbesartan Substances 0.000 claims 3
- YCPOHTHPUREGFM-UHFFFAOYSA-N irbesartan Chemical compound O=C1N(CC=2C=CC(=CC=2)C=2C(=CC=CC=2)C=2[N]N=NN=2)C(CCCC)=NC21CCCC2 YCPOHTHPUREGFM-UHFFFAOYSA-N 0.000 claims 3
- 229960002198 irbesartan Drugs 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 claims 2
- 239000002934 diuretic Substances 0.000 claims 2
- 229940030606 diuretics Drugs 0.000 claims 2
- 229960002003 hydrochlorothiazide Drugs 0.000 claims 2
- 229940118365 Endothelin receptor antagonist Drugs 0.000 claims 1
- 206010064911 Pulmonary arterial hypertension Diseases 0.000 claims 1
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 claims 1
- 102000002852 Vasopressins Human genes 0.000 claims 1
- 108010004977 Vasopressins Proteins 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000003146 anticoagulant agent Substances 0.000 claims 1
- 229940127219 anticoagulant drug Drugs 0.000 claims 1
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 claims 1
- GJPICJJJRGTNOD-UHFFFAOYSA-N bosentan Chemical compound COC1=CC=CC=C1OC(C(=NC(=N1)C=2N=CC=CN=2)OCCO)=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1 GJPICJJJRGTNOD-UHFFFAOYSA-N 0.000 claims 1
- 229960003065 bosentan Drugs 0.000 claims 1
- 229940082638 cardiac stimulant phosphodiesterase inhibitors Drugs 0.000 claims 1
- 239000002308 endothelin receptor antagonist Substances 0.000 claims 1
- 229960001123 epoprostenol Drugs 0.000 claims 1
- KAQKFAOMNZTLHT-VVUHWYTRSA-N epoprostenol Chemical compound O1C(=CCCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-VVUHWYTRSA-N 0.000 claims 1
- 239000002571 phosphodiesterase inhibitor Substances 0.000 claims 1
- 208000002815 pulmonary hypertension Diseases 0.000 claims 1
- 239000002464 receptor antagonist Substances 0.000 claims 1
- 229940044551 receptor antagonist Drugs 0.000 claims 1
- 229940124549 vasodilator Drugs 0.000 claims 1
- 239000003071 vasodilator agent Substances 0.000 claims 1
- 229960003726 vasopressin Drugs 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0113936A FR2831446B1 (fr) | 2001-10-26 | 2001-10-26 | Utilisation de l'irbesartan pour la preparation de medicaments utiles pour la prevention ou le traitement de l'hypertension pulmonaire |
| PCT/FR2002/003439 WO2003035062A1 (fr) | 2001-10-26 | 2002-10-09 | Utilisation de l'irbesartan pour la preparation de medicaments utiles pour la prevention ou le traitement de l'hypertension pulmonaire |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005506369A JP2005506369A (ja) | 2005-03-03 |
| JP2005506369A5 true JP2005506369A5 (enExample) | 2006-01-05 |
| JP4542777B2 JP4542777B2 (ja) | 2010-09-15 |
Family
ID=8868812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003537629A Expired - Fee Related JP4542777B2 (ja) | 2001-10-26 | 2002-10-09 | 肺高血圧症を予防または治療するのに用いられる医薬の製造のためのイルベサルタンの使用 |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US20040242567A1 (enExample) |
| EP (1) | EP1441723B1 (enExample) |
| JP (1) | JP4542777B2 (enExample) |
| CN (1) | CN100418526C (enExample) |
| AT (1) | ATE361071T1 (enExample) |
| AU (1) | AU2002350832B2 (enExample) |
| BR (1) | BR0213479A (enExample) |
| CA (1) | CA2461625C (enExample) |
| CY (1) | CY1106746T1 (enExample) |
| DE (1) | DE60219940T2 (enExample) |
| DK (1) | DK1441723T3 (enExample) |
| EA (1) | EA007952B1 (enExample) |
| ES (1) | ES2286304T3 (enExample) |
| FR (1) | FR2831446B1 (enExample) |
| HU (1) | HUP0401633A3 (enExample) |
| IL (2) | IL161116A0 (enExample) |
| IS (1) | IS2849B (enExample) |
| MX (1) | MXPA04003910A (enExample) |
| NO (1) | NO332313B1 (enExample) |
| NZ (1) | NZ532130A (enExample) |
| PL (1) | PL209263B1 (enExample) |
| PT (1) | PT1441723E (enExample) |
| WO (1) | WO2003035062A1 (enExample) |
| ZA (1) | ZA200402696B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8912174B2 (en) | 2003-04-16 | 2014-12-16 | Mylan Pharmaceuticals Inc. | Formulations and methods for treating rhinosinusitis |
| US9808471B2 (en) | 2003-04-16 | 2017-11-07 | Mylan Specialty Lp | Nasal pharmaceutical formulations and methods of using the same |
| US7811606B2 (en) | 2003-04-16 | 2010-10-12 | Dey, L.P. | Nasal pharmaceutical formulations and methods of using the same |
| US20040265238A1 (en) * | 2003-06-27 | 2004-12-30 | Imtiaz Chaudry | Inhalable formulations for treating pulmonary hypertension and methods of using same |
| TR200301553A1 (tr) * | 2003-09-18 | 2005-10-21 | Nobel �La� Sanay�� Ve T�Caret A.�. | İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar |
| US8226977B2 (en) | 2004-06-04 | 2012-07-24 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical composition containing irbesartan |
| WO2006067601A1 (en) * | 2004-12-23 | 2006-06-29 | Ranbaxy Laboratories Limited | Oral pharmaceutical compositions of irbesartan and hydrochlorothiazide and processes for their preparation |
| CN100367959C (zh) * | 2006-08-29 | 2008-02-13 | 陈俊云 | 一种含有依贝沙坦的药物 |
| GB0617171D0 (en) * | 2006-08-31 | 2006-10-11 | Generics Uk Ltd | Novel compositions and methods |
| AU2022244585A1 (en) * | 2021-03-23 | 2023-09-21 | Dimerix Bioscience Pty Ltd | Treatment of inflammatory diseases |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5258510A (en) * | 1989-10-20 | 1993-11-02 | Otsuka Pharma Co Ltd | Benzoheterocyclic compounds |
| US5270317A (en) * | 1990-03-20 | 1993-12-14 | Elf Sanofi | N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present |
| TW201738B (enExample) * | 1990-03-20 | 1993-03-11 | Sanofi Co | |
| RU2086544C1 (ru) * | 1991-06-13 | 1997-08-10 | Хоффманн-Ля Рош АГ | Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина |
| US5292741A (en) * | 1992-08-18 | 1994-03-08 | Merck & Co., Inc. | Macrocycles incorporating quinazolinones |
| EP1106210A3 (en) | 1999-12-07 | 2003-12-03 | Pfizer Products Inc. | Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications |
-
2001
- 2001-10-26 FR FR0113936A patent/FR2831446B1/fr not_active Expired - Fee Related
-
2002
- 2002-10-09 ES ES02785535T patent/ES2286304T3/es not_active Expired - Lifetime
- 2002-10-09 CN CNB028213041A patent/CN100418526C/zh not_active Expired - Fee Related
- 2002-10-09 IL IL16111602A patent/IL161116A0/xx unknown
- 2002-10-09 HU HU0401633A patent/HUP0401633A3/hu unknown
- 2002-10-09 EA EA200400438A patent/EA007952B1/ru not_active IP Right Cessation
- 2002-10-09 MX MXPA04003910A patent/MXPA04003910A/es active IP Right Grant
- 2002-10-09 DE DE60219940T patent/DE60219940T2/de not_active Expired - Lifetime
- 2002-10-09 PL PL368737A patent/PL209263B1/pl unknown
- 2002-10-09 JP JP2003537629A patent/JP4542777B2/ja not_active Expired - Fee Related
- 2002-10-09 AU AU2002350832A patent/AU2002350832B2/en not_active Ceased
- 2002-10-09 NZ NZ532130A patent/NZ532130A/en not_active IP Right Cessation
- 2002-10-09 DK DK02785535T patent/DK1441723T3/da active
- 2002-10-09 US US10/492,804 patent/US20040242567A1/en not_active Abandoned
- 2002-10-09 CA CA2461625A patent/CA2461625C/en not_active Expired - Fee Related
- 2002-10-09 PT PT02785535T patent/PT1441723E/pt unknown
- 2002-10-09 WO PCT/FR2002/003439 patent/WO2003035062A1/fr not_active Ceased
- 2002-10-09 BR BR0213479-9A patent/BR0213479A/pt not_active Application Discontinuation
- 2002-10-09 EP EP02785535A patent/EP1441723B1/fr not_active Expired - Lifetime
- 2002-10-09 AT AT02785535T patent/ATE361071T1/de active
-
2004
- 2004-03-25 IL IL161116A patent/IL161116A/en not_active IP Right Cessation
- 2004-03-29 IS IS7200A patent/IS2849B/is unknown
- 2004-04-06 ZA ZA2004/02696A patent/ZA200402696B/en unknown
- 2004-04-23 NO NO20041732A patent/NO332313B1/no not_active IP Right Cessation
-
2007
- 2007-07-19 CY CY20071100964T patent/CY1106746T1/el unknown
-
2009
- 2009-06-03 US US12/477,562 patent/US8088827B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE461932T1 (de) | Pyrazoloä4,3-eü-1,2,4-triazoloä1,5-cüpyrimidine als antagonisten des adenosin-a2a-rezeptors | |
| JP2005506369A5 (enExample) | ||
| WO2004096798A3 (fr) | Derives de 2-acylamino-4-phenylthiazole, leur preparation et leur application en therapeutique | |
| BR0313629B1 (pt) | composiÇço detergente bifÁsica lÍquida aquosa de limpeza pessoal. | |
| UY27127A1 (es) | Derivados de la urea como antagonistas de integrin alfa-4 | |
| BR9911621A (pt) | Bifenil sulfonamidas como antagonista duplos de receptor de angiotensina endotelina | |
| DE122012000018I1 (de) | Benzimidazolderivate und ihre verwendung als antagonisten des a II rezeptors. | |
| WO2002081430A3 (en) | Novel benzylideneamino guanidines and their uses as ligands to the melanocortin receptors | |
| WO2006044362A3 (en) | N-sulfonylpiperidine cannabinoid receptor 1 antagonists | |
| JP2005526147A5 (enExample) | ||
| MX2009005174A (es) | Derivados de 5-sulfanilmetil-[1,2,4]triazol[1,5-a]pirimidin-7-ol como antagonistas de cxcr2. | |
| JP2006517944A5 (enExample) | ||
| JP2007524571A5 (enExample) | ||
| JP2004520453A5 (enExample) | ||
| EP1195166A3 (en) | Use of a vasopressin antagonist such as conivaptan in the manufacture of a medicament for treating pulmonary hypertension | |
| JP2007191765A5 (enExample) | ||
| NO20075662L (no) | Roflumilast for behandlingen av pulmonal hypertensjon | |
| JP2007510403A5 (enExample) | ||
| WO2007075964A3 (en) | Thrombin receptor antagonists as prophylaxis to complications from cardiopulmonary surgery | |
| WO2005075450A3 (en) | Spiro-benzodioxoles and their use as cb1 antagonists | |
| WO2005000231A3 (en) | Il-8 receptor antagonists | |
| JP2004534810A5 (enExample) | ||
| JP2008534513A5 (enExample) | ||
| WO2001072960A3 (en) | Il-8 receptor antagonists | |
| ECSP066306A (es) | Modificaciones estables de maleato ácido de tegaserod |